[Fundamentals of the chemotherapy of trichomoniasis and amebiasis with ornidazole].
D000328:Adult; D000562:Amebiasis / Q000188:drug therapy*; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D006224:Cricetinae; D004285:Dogs; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008297:Male; D008647:Mesocricetus; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009950:Ornidazole / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D011247:Pregnancy; D051381:Rats; D013723:Teratogens; D014245:Trichomonas Infections / Q000188:drug therapy*
D009593:Nitroimidazoles; D013723:Teratogens; D008795:Metronidazole; D009950:Ornidazole
Grundlagen der Chemotherapie von Trichomoniasis und Amoebiasis mit Ornidazol.